Shape-En-Resist (101164533)

  https://cordis.europa.eu/project/id/101164533

  Horizon Europe (2021-2027)

  Shaping the bacterial envelope: Interplay between the components and impact on antibiotic resistance

  ERC STARTING GRANTS (ERC-2024-STG)

  proteins  ·  antibiotics

  2025-01-01 Start Date (YY-MM-DD)

  2029-12-31 End Date (YY-MM-DD)

  € 1,499,894 Total Cost


  Description

Gram-negative bacteria are notoriously resilient, dominating the list of pathogens requiring urgent medical attention. Fundamental to their remarkable antibiotic resistance is a tripartite envelope comprised of an inner-membrane (IM), peptidoglycan cell wall (PG) and an outer membrane (OM). While these layers were previously viewed as separate compartments, it is becoming apparent that they work together in order to maintain envelope integrity. However, little is known about the crosstalk between components and molecular mechanisms orchestrating envelope assembly and functionality. Our latest work has identified a key interaction between the PG and the BAM complex which inserts new OM proteins (OMPs), revealing a mechanism coordinating PG and OMP biogenesis and directing them both to the cell center. We posit that coordination is a key principle of envelope assembly and multiple interactions among envelope constituents are waiting to be discovered. In Shape-En-Resist we will uncover novel physical and genetic interactions, identify coordination mechanisms and elucidate their impact on bacterial physiology and antibiotic resistance. To this end, we will focus on three aims: (i) Explore the assembly of lipopolysaccharide (LPS), an endotoxin covering the bacterial surface, and characterize its interplay with envelope biogenesis. (ii) Comprehensively map PG-OMPs interactions and study how they affect bacterial response to antibiotics. (iii) Uncover the outcomes of spatially heterogenous envelope biogenesis and whether this process is a source of phenotypic diversity. To address these questions, a multidisciplinary approach will be taken, combining cutting-edge microscopy, advanced genetic screens, proteomics and novel functionality assays. We expect this project to uncover the interaction network amongst envelope components, reveal how it impacts the physiology of both single cells and bacterial populations, and ultimately expose the secrets of bacterial resilience.


  Complicit Organisations

1 Israeli organisation participates in Shape-En-Resist.

Country Organisation (ID) VAT Number Role Activity Type Total Cost EC Contribution Net EC Contribution
Israel THE HEBREW UNIVERSITY OF JERUSALEM (999975038) IL500701610 coordinator HES € 1,499,894 € 1,499,894 € 1,499,894